{"id":77,"date":"2024-03-14T18:39:45","date_gmt":"2024-03-14T18:39:45","guid":{"rendered":"https:\/\/ecngx348.inmotionhosting.com\/~astrpa5\/?page_id=77"},"modified":"2026-03-24T14:28:22","modified_gmt":"2026-03-24T14:28:22","slug":"home-2","status":"publish","type":"page","link":"https:\/\/astrpartners.com\/","title":{"rendered":"Home"},"content":{"rendered":"\n
\n
\"\"<\/span>
\n
\n
\n
\n
\n

Network Capital Innovation<\/h2>\n\n\n\n

Named for the corner of Astor Place and Broadway in New York City, a location reminding us of teamwork and collaboration at the center of the capital markets ecosystem supporting biotech companies.<\/p>\n<\/div>\n\n\n\n

\n
\n
Contact Us<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n\n\n\n
\n
\n
\n
\n
\n
\n
<\/div>\n\n\n\n

The Problem<\/h3>\n\n\n\n
\n

The explosion of company creation over the last several years has provided challenges for the buy and sell-side as well as service providers.  No one has the capacity to service, sort, support and fund all these companies; the mechanisms created over the last 2 decades are failing in this current
paradigm.<\/p>\n<\/div>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
<\/i><\/div><\/div>\n\n\n\n
<\/div>\n\n\n\n

Creating a new category to help biotech companies:<\/h3>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n

We are building a framework to expedite funding of quality companies with important drugs in development for patients with unmet needs.<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n
\"\"<\/span>
\n
\n
\n

25+<\/h2>\n<\/div>\n\n\n\n

Years of
Experience<\/h3>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n

WHY CHOOSE US<\/strong><\/p>\n<\/div>\n\n\n\n

Purpose-Built Exclusive Network for Value Creation<\/h2>\n\n\n\n

astr partners is building an exclusive network purpose-built to support life science investors and their priority portfolio companies. Our strategic corporate development support, capital advisory and investor access support will address the needs of biotech companies in a collaborative way while ensuring their stories are in front of the top minds in the space. We are also curating a network of capital outside of the biotech community interested in meeting top idea flow from specialists.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n

\n
<\/div>\n\n\n\n
\n
\n

REFERRAL NETWORK<\/strong><\/p>\n<\/div>\n\n\n\n

astr partners is operating on a referral only basis through our network of specialist investors.<\/h2>\n\n\n\n
\n
\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n
\n
\n
<\/i><\/div><\/div>\n\n\n\n
\n

Collaboration<\/h3>\n<\/div>\n\n\n\n

We will connect all parts of the capital markets ecosystem and leverage the value each component can bring: bankers, analysts, salespeople, traders, current investors, consultants, service providers, KOLs, board members and management.<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
<\/i><\/div><\/div>\n\n\n\n

Focus<\/h3>\n\n\n\n
\n
<\/div>\n<\/div>\n\n\n\n

Our focus is to ultimately create incremental buying in the stock at varying points in time based on milestone progression, helping efficiently expedite funding of quality companies.<\/p>\n\n\n\n

astr partners believes that by being exclusive and curated<\/strong>\u2014focusing on a small group of companies\u2014we can effectively build a network of high-quality investors and address the capital needs of top biotech companies.<\/p>\n\n\n\n

<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\n

Our Team<\/strong><\/p>\n<\/div>\n\n\n\n

Leadership with Proven track record<\/h2>\n<\/div>\n\n\n\n

astr partners is founded by Jonathan Fassberg and Brian Korb, a team with a track record of building
networks and supporting biotech companies, leveraging both their IR and banking expertise. Matthew
Beck also joined the team, with 20+ years of internal and external IR and capital markets experience.
Deep support from a senior team.<\/p>\n<\/div>\n\n\n\n

\n
<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure>\n\n\n\n
Jonathan Fassberg<\/a><\/h5>\n\n\n\n

Managing Partner<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Brian Korb<\/a><\/h3>\n\n\n\n

Managing Partner<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Matthew Beck<\/a><\/h3>\n\n\n\n

Managing Partner<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Candice Masse<\/a><\/h3>\n\n\n\n

Managing Director, Boston<\/h4>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure>\n\n\n\n
Josh Barer<\/a><\/h5>\n\n\n\n

Managing Director<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Ron Grant <\/a><\/h3>\n\n\n\n

Chief Operating Officer<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Guillaume Cabon<\/a><\/h3>\n\n\n\n

Head of Europe\/UK<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Bob Ai<\/a><\/h3>\n\n\n\n

Head of Greater Asia<\/h4>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure>\n\n\n\n
Hanna Erdtmann<\/a><\/h5>\n\n\n\n

Sr. Associate, EU\/Amsterdam<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Sebastian Gomez<\/a><\/h3>\n\n\n\n

Associate<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

William Thorp<\/a><\/h3>\n\n\n\n

Associate<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Lauren McNealey<\/a><\/h3>\n\n\n\n

Analyst<\/h4>\n<\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure>\n\n\n\n
Ariane Stenstedt<\/a><\/h5>\n\n\n\n

Analyst<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n\n\n\n

Ed Saltzman<\/a><\/h3>\n\n\n\n

Senior Advisor<\/h4>\n<\/div><\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n
<\/div>\n<\/div>\n\n\n\n

<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

The Problem The explosion of company creation over the last several years has provided challenges […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-no-title","meta":{"gutenify_custom_css":"","gutenify_custom_css_data":"","footnotes":""},"class_list":["post-77","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/astrpartners.com\/index.php?rest_route=\/wp\/v2\/pages\/77","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/astrpartners.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/astrpartners.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/astrpartners.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/astrpartners.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=77"}],"version-history":[{"count":95,"href":"https:\/\/astrpartners.com\/index.php?rest_route=\/wp\/v2\/pages\/77\/revisions"}],"predecessor-version":[{"id":300,"href":"https:\/\/astrpartners.com\/index.php?rest_route=\/wp\/v2\/pages\/77\/revisions\/300"}],"wp:attachment":[{"href":"https:\/\/astrpartners.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=77"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}